668 related articles for article (PubMed ID: 32897584)
1. A network meta-analysis on the efficacy and safety of monotherapies for tinea capitis, and an assessment of evidence quality.
Gupta AK; Bamimore MA; Renaud HJ; Shear NH; Piguet V
Pediatr Dermatol; 2020 Nov; 37(6):1014-1022. PubMed ID: 32897584
[TBL] [Abstract][Full Text] [Related]
2. Systemic antifungal therapy for tinea capitis in children.
Chen X; Jiang X; Yang M; González U; Lin X; Hua X; Xue S; Zhang M; Bennett C
Cochrane Database Syst Rev; 2016 May; 2016(5):CD004685. PubMed ID: 27169520
[TBL] [Abstract][Full Text] [Related]
3. Systemic antifungal therapy for tinea capitis in children.
González U; Seaton T; Bergus G; Jacobson J; Martínez-Monzón C
Cochrane Database Syst Rev; 2007 Oct; (4):CD004685. PubMed ID: 17943825
[TBL] [Abstract][Full Text] [Related]
4. Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials.
Elewski BE; Cáceres HW; DeLeon L; El Shimy S; Hunter JA; Korotkiy N; Rachesky IJ; Sanchez-Bal V; Todd G; Wraith L; Cai B; Tavakkol A; Bakshi R; Nyirady J; Friedlander SF
J Am Acad Dermatol; 2008 Jul; 59(1):41-54. PubMed ID: 18378354
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole.
Gupta AK; Adam P; Dlova N; Lynde CW; Hofstader S; Morar N; Aboobaker J; Summerbell RC
Pediatr Dermatol; 2001; 18(5):433-8. PubMed ID: 11737692
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species.
Lipozencic J; Skerlev M; Orofino-Costa R; Zaitz VC; Horvath A; Chouela E; Romero G; Gourmala N; Paul C;
Br J Dermatol; 2002 May; 146(5):816-23. PubMed ID: 12000378
[TBL] [Abstract][Full Text] [Related]
7. Tinea capitis in children: a systematic review of management.
Gupta AK; Mays RR; Versteeg SG; Piraccini BM; Shear NH; Piguet V; Tosti A; Friedlander SF
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2264-2274. PubMed ID: 29797669
[TBL] [Abstract][Full Text] [Related]
8. Treatment outcomes for tinea capitis in a skin of color population.
Bhanusali D; Coley M; Silverberg JI; Alexis A; Silverberg NB
J Drugs Dermatol; 2012 Jul; 11(7):852-6. PubMed ID: 22777228
[TBL] [Abstract][Full Text] [Related]
9. A random comparative study of terbinafine versus griseofulvin in patients with tinea capitis in Western China.
Deng S; Hu H; Abliz P; Wan Z; Wang A; Cheng W; Li R
Mycopathologia; 2011 Nov; 172(5):365-72. PubMed ID: 21701791
[TBL] [Abstract][Full Text] [Related]
10. New treatments for tinea capitis.
Chan YC; Friedlander SF
Curr Opin Infect Dis; 2004 Apr; 17(2):97-103. PubMed ID: 15021047
[TBL] [Abstract][Full Text] [Related]
11. Comparison of terbinafine and griseofulvin in the treatment of tinea capitis.
Cáceres-Ríos H; Rueda M; Ballona R; Bustamante B
J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):80-4. PubMed ID: 10607324
[TBL] [Abstract][Full Text] [Related]
12. Efficacy, safety and tolerability of terbinafine for Tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1,2 and 4 weeks.
Filho ST; Cucé LC; Foss NT; Marques SA; Santamaria JR
J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):141-6. PubMed ID: 9784040
[TBL] [Abstract][Full Text] [Related]
13. Griseofulvin versus terbinafine in the treatment of tinea capitis: a meta-analysis of randomized, clinical trials.
Fleece D; Gaughan JP; Aronoff SC
Pediatrics; 2004 Nov; 114(5):1312-5. PubMed ID: 15520113
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of randomized, controlled trials comparing particular doses of griseofulvin and terbinafine for the treatment of tinea capitis.
Gupta AK; Drummond-Main C
Pediatr Dermatol; 2013; 30(1):1-6. PubMed ID: 22994156
[TBL] [Abstract][Full Text] [Related]
15. Systemic antifungal therapy for tinea capitis in children: An abridged Cochrane Review.
Chen X; Jiang X; Yang M; Bennett C; González U; Lin X; Hua X; Xue S; Zhang M
J Am Acad Dermatol; 2017 Feb; 76(2):368-374. PubMed ID: 27816294
[TBL] [Abstract][Full Text] [Related]
16. Tinea Capitis: An Updated Review.
Leung AKC; Hon KL; Leong KF; Barankin B; Lam JM
Recent Pat Inflamm Allergy Drug Discov; 2020; 14(1):58-68. PubMed ID: 31906842
[TBL] [Abstract][Full Text] [Related]
17. Guidelines for the management of tinea capitis in children.
Kakourou T; Uksal U;
Pediatr Dermatol; 2010; 27(3):226-8. PubMed ID: 20609140
[TBL] [Abstract][Full Text] [Related]
18. Tinea capitis.
Gupta AK; Summerbell RC
Med Mycol; 2000 Aug; 38(4):255-87. PubMed ID: 10975696
[TBL] [Abstract][Full Text] [Related]
19. Management of tinea capitis in Israel: A comparative study.
Shemer A; Gupta AK; Galili E; Daniel R; Kassem R; Farhi R; Grunwald H; Bamimore MA
Pediatr Dermatol; 2021 Jul; 38(4):806-811. PubMed ID: 33998709
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled trial assessing the efficacy of fluconazole in the treatment of pediatric tinea capitis.
Foster KW; Friedlander SF; Panzer H; Ghannoum MA; Elewski BE
J Am Acad Dermatol; 2005 Nov; 53(5):798-809. PubMed ID: 16243128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
